Research
Evidence with its limits left intact.
Explore 20 research records by topic, study type, wavelength, evidence level, and format relevance. Every public record is category-level evidence, not proof of the rePretty Mat.
Evidence Explorer
Filter the record, then read the limitation.
Cards summarize selected outcomes and always link to the original source. They do not reproduce the paper or convert a category finding into a product claim.
de Freitas LF, Hamblin MR. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy. 2016.
Summarizes mitochondrial, nitric oxide, reactive oxygen species, calcium, and transcription pathways proposed in PBM.
- Evidence
- Not graded
- Light
- Red and near-infrared
- Scope
- Category-level
Hamblin MR. Mechanisms and Applications of the Anti-Inflammatory Effects of Photobiomodulation. 2017.
Describes proposed anti-inflammatory signaling pathways and emphasizes wavelength and dose dependence.
- Evidence
- Not graded
- Light
- Red and near-infrared
- Scope
- Category-level
Heiskanen V, Hamblin MR. Photobiomodulation: Lasers vs Light Emitting Diodes? 2018.
Concludes that both lasers and LEDs can be used for PBM while optical delivery and dosimetry remain important.
- Evidence
- Not graded
- Light
- Red and near-infrared
- Scope
- Category-level
Serrage H et al. Under the Spotlight: Mechanisms of Photobiomodulation. 2019.
Reviews proposed molecular pathways and identifies unresolved questions in PBM mechanism research.
- Evidence
- Not graded
- Light
- Red and near-infrared
- Scope
- Category-level
Liebert A et al. Photophysical Mechanisms of Photobiomodulation Therapy as Precision Medicine. 2023.
Proposes mechanisms beyond cytochrome c oxidase, including ion-channel and protein-interaction pathways.
- Evidence
- Not graded
- Light
- Red and near-infrared
- Scope
- Category-level
Light Buckets and Laser Beams: Mechanisms and Applications of Photobiomodulation Therapy. 2025.
Identifies multiple plausible mechanisms and prioritizes protocol specificity, dose estimation, and standardization.
- Evidence
- Not graded
- Light
- Red and near-infrared
- Scope
- Category-level
Therapeutic Efficacy of Home-Use Photobiomodulation Devices: A Systematic Literature Review. 2019.
Most included studies reported positive outcomes, but the authors called for additional randomized controlled studies.
- Evidence
- Low
- Light
- Near-infrared
- Scope
- Category-level
Photobiomodulation LED Devices for Home Use: Design, Function and Potential: A Pilot Study. 2025.
Found heterogeneous optical performance and inconsistencies between measured dosimetry and consumer instructions.
- Evidence
- Very low
- Light
- Red and near-infrared
- Scope
- Category-level
Safety of Light Emitting Diode-Red Light on Human Skin: Two Randomized Controlled Trials. 2022.
No serious adverse events were reported, while dose-limiting erythema or blistering occurred at the highest exposures.
- Evidence
- Low
- Light
- Red light
- Scope
- Category-level
Maghfour J et al. Evidence-Based Consensus on the Clinical Application of Photobiomodulation. 2025.
Produced consensus statements for selected clinical applications and adult safety based on the reviewed evidence.
- Evidence
- Moderate
- Light
- Red and near-infrared
- Scope
- Category-level
Effects of Low-Level Laser Therapy on Muscular Performance and Soreness Recovery in Athletes: A Meta-Analysis of Randomized Controlled Trials. 2021.
Reported improvements in some strength and soreness-recovery outcomes, while stating that a definite therapeutic effect was not established.
- Evidence
- Low
- Light
- Red and near-infrared
- Scope
- Category-level
A Systematic Review on Whole-Body Photobiomodulation for Exercise Performance and Recovery. 2025.
No included study reported benefits for exercise performance or fatigue biomarkers; sleep findings were preliminary and inconsistent with localized PBM literature.
- Evidence
- Very low
- Light
- Red and near-infrared
- Scope
- Category-level
Comparison Between Cryotherapy and Photobiomodulation in Muscle Recovery: A Systematic Review and Meta-Analysis. 2021.
Pooled estimates favored PBM for selected strength, soreness, and muscle-damage outcomes compared with cryotherapy.
- Evidence
- Very low
- Light
- Red and near-infrared
- Scope
- Category-level
Can Photobiomodulation Therapy Minimize Exercise-Induced Oxidative Stress? A Systematic Review and Meta-Analysis. 2022.
Low-to-moderate certainty findings suggested changes in selected oxidative-damage and antioxidant biomarkers, but not all biomarkers.
- Evidence
- Low
- Light
- Red and near-infrared
- Scope
- Category-level
Can Pre-Exercise Photobiomodulation Improve Muscle Endurance and Promote Recovery? A Meta-Analysis of Randomized Controlled Trials. 2024.
Reported modest pooled improvements in endurance and selected recovery measures, with different findings across activity-level subgroups.
- Evidence
- Low
- Light
- Red and near-infrared
- Scope
- Category-level
Effects of Photobiomodulation, Intermittent Pneumatic Compression and Neuromuscular Electrical Stimulation on Muscle Recovery: Systematic Review with Meta-Analysis. 2025.
Low-certainty evidence suggested pre-exercise PBM reduced soreness and improved selected performance outcomes at follow-up.
- Evidence
- Low
- Light
- Red and near-infrared
- Scope
- Category-level
Does Phototherapy Enhance Skeletal Muscle Contractile Function and Postexercise Recovery? A Systematic Review. 2013.
Most analyzed data sets favored active phototherapy for selected fatigue, performance, or recovery measures.
- Evidence
- Low
- Light
- Red and near-infrared
- Scope
- Category-level
Low-Level Phototherapy to Improve Exercise Capacity and Muscle Performance: A Systematic Review and Meta-Analysis. 2016.
Pooled laser studies favored selected exercise-capacity outcomes, while the limited LED subset did not show significant differences for several outcomes.
- Evidence
- Low
- Light
- Red and near-infrared
- Scope
- Category-level
Effects of Low-Level Laser Therapy on Pain in Patients with Musculoskeletal Disorders: A Systematic Review and Meta-Analysis. 2017.
Pooled results favored LLLT for pain, with high between-study heterogeneity and larger estimates in WALT-adherent studies.
- Evidence
- Low
- Light
- Red and near-infrared
- Scope
- Category-level
Photobiomodulation in Chronic Pain: A Systematic Review of Randomized Clinical Trials. 2026.
Most included trials reported pain reductions, but technical heterogeneity and limited follow-up prevented broad standardized recommendations.
- Evidence
- Low
- Light
- Red and near-infrared
- Scope
- Category-level
Transfer boundary
A study can inform a question without proving a product.
Device type, wavelength, irradiance, dose, treatment area, timing, population, and outcome must be compared before evidence can transfer. rePretty publishes the mismatch instead of hiding it.
How records are reviewed